|
مقاله
|
Abstract
|
|
|
Title:
|
Modified deep sclerectomy for surgical treatment of glaucoma
|
Author(s):
|
Farideh Sharifipour, MD; Shahin Yazdani, MD; Mona Asadi, MD; Azadeh Saki, PhD
|
Presentation Type:
|
Oral
|
Subject:
|
Glaucoma
|
Others:
|
|
Presenting Author:
|
|
Name:
|
Farideh Sharifipour
|
Affiliation :(optional)
|
Department of Ophthalmology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
|
E mail:
|
sharifipourf@yahoo.com
|
Phone:
|
4440063
|
Mobile:
|
09161117223
|
|
|
Purpose:
|
To report the short term results of a modified deep sclerectomy (MDS) technique for surgical management of glaucoma.
|
Methods:
|
This prospective, non-randomized clinical trial consisted of 102 open angle glaucoma patients scheduled for glaucoma surgery alone or combined with cataract surgery. They were assigned into 4 groups including trabeculectomy (TE) and MDS alone and combined with phacoemulsification. MDS included a third scleral flap removal to expose suprachoroidal space and removing a trabecular block similar to TE. Intraocular pressure (IOP), number of medications, and complications over a period of 6 months were compared.
|
Results:
|
All groups showed significant decrease in IOP and number of glaucoma medications. (All Ps<0.001) Although IOP was significantly higher in MDS group both at baseline and 6 months compared to TE group, both groups showed similar IOP reduction. (P=0.391) MDS group needed more medications at 6 months. (P=0.006) PMDS group had similar IOPs at baseline and 6 months, (P=0.324, and 0.469, respectively) more medications at baseline (P=0.031) and similar number of medications after 6 months compared to PT group. (P=0.761) TE and PT groups had more complications (P=0.043)
|
Conclusion:
|
MDS has similar efficacy and higher safety profile compared to TE and technically easier than conventional DS.
|
Attachment:
|
|
|